{"id":2822,"date":"2023-06-11T17:31:24","date_gmt":"2023-06-11T17:31:24","guid":{"rendered":"https:\/\/proboostnow.eu\/?p=2822"},"modified":"2024-07-18T14:04:44","modified_gmt":"2024-07-18T14:04:44","slug":"proboost-tpa-a-terapie-fip","status":"publish","type":"post","link":"https:\/\/proboostnow.eu\/en_us\/2023\/06\/11\/proboost-tpa-a-terapie-fip\/","title":{"rendered":"ProBoost-TPA a terapie FIP"},"content":{"rendered":"<div class=\"banner has-hover bg-fade-out\" id=\"banner-1590529033\">\n          <div class=\"banner-inner fill\">\n        <div class=\"banner-bg fill\" >\n            <img loading=\"lazy\" decoding=\"async\" width=\"1020\" height=\"791\" src=\"https:\/\/proboostnow.eu\/wp-content\/uploads\/2023\/06\/Screenshot-2023-06-11-194748-1024x794.png\" class=\"bg attachment-large size-large\" alt=\"FIP\" \/>                                    \n                    <\/div>\n\t\t\n        <div class=\"banner-layers container\">\n            <div class=\"fill banner-link\"><\/div>            \n\n   <div id=\"text-box-553158466\" class=\"text-box banner-layer x50 md-x50 lg-x50 y5 md-y5 lg-y5 res-text\">\n                                <div class=\"text-box-content text dark\">\n              \n              <div class=\"text-inner text-center\">\n                  \n\n\t<div id=\"text-3757605484\" class=\"text\">\n\t\t\n\n<h2>TPA lze jako jedin\u00fd imunomodulant pou\u017e\u00edvat b\u011bhem l\u00e9\u010dby FIP antivirotiky<\/h2>\n<p>&nbsp;<\/p>\n\t\t\n<style>\n#text-3757605484 {\n  color: rgb(0,0,0);\n}\n#text-3757605484 > * {\n  color: rgb(0,0,0);\n}\n<\/style>\n\t<\/div>\n\t\n\n              <\/div>\n           <\/div>\n                            \n<style>\n#text-box-553158466 {\n  width: 98%;\n}\n#text-box-553158466 .text-box-content {\n  font-size: 100%;\n}\n<\/style>\n    <\/div>\n \n\n        <\/div>\n      <\/div>\n\n            \n<style>\n#banner-1590529033 {\n  padding-top: 500px;\n}\n#banner-1590529033 .banner-bg img {\n  object-position: 42% 0%;\n}\n<\/style>\n  <\/div>\n\n\n<div class=\"row\"  id=\"row-817245131\">\n\n\n\t<div id=\"col-1141923704\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<div id=\"row-1299798863\" class=\"row\">\n<div id=\"col-901985212\" class=\"col small-12 large-12\">\n<div class=\"col-inner\">\n<div class=\"__fb-light-mode x1n2onr6\" role=\"row\">\n<div class=\"\">\n<div class=\"x78zum5 xdt5ytf x1n2onr6\" tabindex=\"0\" role=\"gridcell\" data-release-focus-from=\"CLICK\" data-scope=\"messages_table\">\n<div>\n<div class=\"x78zum5\" role=\"none\">\n<div class=\"x78zum5 x1iyjqo2 xs83m0k xeuugli x15zctf7\" role=\"none\">\n<div class=\"x1h91t0o xkh2ocl x78zum5 xdt5ytf x13a6bvl x1r145dm\" role=\"none\">\n<div class=\"x78zum5 xh8yej3\" role=\"none\">\n<div class=\"x78zum5 xdt5ytf x193iq5w x1n2onr6 xuk3077\">\n<div class=\"x78zum5 xh8yej3\" role=\"none\">\n<div class=\"x1tlxs6b x1g8br2z x1gn5b1j x230xth x14ctfv x1okitfd x6ikm8r x10wlt62 x1mzt3pk x1y1aw1k xn6708d xwib8y2 x1ye3gou x1n2onr6 x13faqbe x1vjfegm\" role=\"none\">\n<div dir=\"auto\" role=\"none\">\n<h4 style=\"text-align: center;\">Thymov\u00fd Protein A (TPA), kter\u00fd je obsa\u017een\u00fd v p\u0159\u00edpravku s n\u00e1zvem ProBoost je d\u00edky unik\u00e1tn\u00edmu \u00fa\u010dinku na\u00a0 imunitn\u00ed syst\u00e9m jedin\u00fdm ov\u011b\u0159en\u00fdm p\u0159\u00edpravkem, kter\u00fd je doporu\u010deno pod\u00e1vat spolu s antivirotiky ji\u017e od prvn\u00edho dne terapie ko\u010dek, kter\u00e9 onemocn\u011bly FIP \u2013 felinn\u00ed infek\u010dn\u00ed peritonitidou.\u00a0\u00a0<\/h4>\n<p>\u00a0<\/p>\n<h2 style=\"text-align: center;\">Pod\u00e1v\u00e1n\u00ed TPA spolu s antivirotiky zvy\u0161uje jistotu uzdraven\u00ed.<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"x78zum5 xh8yej3\" role=\"none\">\n<div class=\"x1tlxs6b x1g8br2z x1gn5b1j x230xth x14ctfv x1okitfd x6ikm8r x10wlt62 x1mzt3pk x1y1aw1k xn6708d xwib8y2 x1ye3gou x1n2onr6 x13faqbe x1vjfegm\" role=\"none\">\n<div class=\"x9f619 x1n2onr6 x1ja2u2z __fb-light-mode\" role=\"none\">\n<div dir=\"auto\" role=\"none\">\u00a0<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>\u00a0 \u00a0 \u00a0 Mezi majiteli ko\u010dek, kter\u00e9 jsou nemocn\u00e9 infek\u010dn\u00ed peritonit\u00eddou je bohu\u017eel dogmaticky roz\u0161\u00ed\u0159en\u00fd n\u00e1zor, \u017ee b\u011bhem terapie antivirotiky nen\u00ed mo\u017en\u00e9 jakkoliv zasahovat do imunitn\u00edch proces\u016f. Je to\u00a0 da\u0148 za neschv\u00e1len\u00ed u\u017e\u00edv\u00e1n\u00ed GS-441524 jako l\u00e9\u010debn\u00e9ho p\u0159\u00edpravku a vznik spont\u00e1nn\u00edch, z v\u011bt\u0161\u00ed \u010d\u00e1sti laick\u00fdch facebookov\u00fdch komunit, kde jsou n\u011bkter\u00e9 metodick\u00e9 pokyny bez pochopen\u00ed princip\u016f otrocky vn\u00edm\u00e1ny jako postul\u00e1ty.\u00a0<\/p>\n<p style=\"text-align: center;\">\u00a0 \u00a0 \u00a0 <strong>Do t\u00e9to kategorie pat\u0159\u00ed obava, \u017ee ProBoost se nesm\u00ed pod\u00e1vat b\u011bhem l\u00e9\u010dby FIP, proto\u017ee podporuje imunitu a to je u FIP zak\u00e1zan\u00e9.<\/strong><\/p>\n<p>Jedn\u00e1 se samoz\u0159ejm\u011b o chybn\u00fd v\u00fdklad nutnosti jakkoliv nezasahovat do stimulace nespecifick\u00fdch a protil\u00e1tkov\u00fdch typ\u016f imunitn\u00edch proces\u016f. Pr\u00e1v\u011b tento druh imunitn\u00ed reakce je toti\u017e u FIP patologicky eskalovan\u00fd a je p\u0159\u00ed\u010dinou projev\u016f onemocn\u011bn\u00ed. ProBoost, resp. Thymov\u00fd Protein A\u00a0 (TPA), kter\u00fd tento p\u0159\u00edpravek obsahuje, je imunomodul\u00e1torem, kter\u00fd p\u016fsob\u00ed na opa\u010dn\u00e9m p\u00f3lu imunitn\u00ed ochrany. Krom\u011b diferencia\u010dn\u00ed signalizace k dozr\u00e1v\u00e1n\u00ed nezral\u00fdch T lymfocyt\u016f do funk\u010dn\u00ed podoby podporuje tak\u00e9 jejich diferenciaci sm\u011brem k bun\u011b\u010dn\u00e9, protivirov\u00e9 imunitn\u00ed odpov\u011bdi.<\/p>\n<div class=\"row\"  id=\"row-594676211\">\n\n\n\t<div id=\"col-207030123\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-2184785370\" class=\"text\">\n\t\t\n\n<p style=\"text-align: center;\"><em>Teoretick\u00e9 imunologick\u00e9 principy pop\u00ed\u0161eme v z\u00e1v\u011bru tohoto p\u0159\u00edsp\u011bvku.<\/em><\/p>\n<ul>\n<li>\n<p class=\"lead\" style=\"text-align: left;\"><strong>FIP vyvol\u00e1v\u00e1 anemii \u2013 TPA stimuluje kostn\u00ed d\u0159e\u0148 k tvorb\u011b nov\u00fdch krvinek.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 Helpery, jejich\u017e mno\u017estv\u00ed TPA zvy\u0161uje stimuluj\u00ed tvorbu \u010derven\u00fdch krvinek, krevn\u00edch desti\u010dek i dal\u0161\u00edch krevn\u00edch bun\u011bk, v\u010detn\u011b b\u00edl\u00fdch krvinek myeloidn\u00edho p\u016fvodu a zab\u00edje\u010dsk\u00fdch NK bun\u011bk a to podle aktu\u00e1ln\u00ed popt\u00e1vky v t\u011ble (cytokinov\u00e1 signalizace).<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>FIP nebezpe\u010dn\u011b sni\u017euje po\u010det lymfocyt\u016f \u2013 TPA zvy\u0161uje po\u010det lymfocyt\u016f.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 TPA akceleruje dozr\u00e1v\u00e1n\u00ed thymocyt\u016f na zral\u00e9 T lymfocyty a zvy\u0161uje jejich po\u010det v krvi.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>FIP je d\u016fsledkem prob\u00edhaj\u00edc\u00ed sebezni\u010duj\u00edc\u00ed p\u0159ehnan\u00e9 protil\u00e1tkov\u00e9 imunitn\u00ed odpov\u011bdi \u2013 TPA tento z\u00e1n\u011bt blokuje t\u00edm, \u017ee stimuluje PROTIVIROVOU bun\u011b\u010dnou reakci na infekci.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 FIP je d\u016fsledkem\/projevem p\u0159ehnan\u00e9 protil\u00e1tkov\u00e9 imunitn\u00ed odpov\u011bdi na infekci typu Th2, p\u0159i\u010dem\u017e blokuje t\u00e9m\u011b\u0159 k nule Th1. TPA in vivo i in vitro stimuluje bun\u011b\u010dnou imunitn\u00ed odpov\u011b\u010f sm\u011brem k Th1 a tak kompeti\u010dn\u011b potla\u010duje u FIP \u0161kodliv\u011b p\u0159ehnanou protil\u00e1tkovou Th2. Zv\u00fd\u0161enou nab\u00eddkou zral\u00fdch T lymfocyt\u016f nav\u00edc poskytuje imunitn\u00edmu syst\u00e9mu n\u00e1stroje (T lymfocyty) pro tento typ obrany.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>FIP se \u0161\u00ed\u0159\u00ed naka\u017een\u00fdmi makrof\u00e1gy \u2013 TPA zvy\u0161uje mno\u017estv\u00ed specifick\u00fdch zabij\u00e1k\u016f t\u011bchto naka\u017een\u00fdch bun\u011bk.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 TPA zvy\u0161uje nab\u00eddku Th0 a n\u00e1sledn\u011b zejm\u00e9na Th1 CD4+ lymfocyt\u016f. Pouze tyto aktivovan\u00e9 bu\u0148ky maj\u00ed schopnost probudit sp\u00edc\u00ed cytotoxick\u00e9 bun\u011b\u010dn\u00e9 zabij\u00e1ky (CD8+ lymfocyty), aktivovat je a d\u00e1t jim sign\u00e1l, aby se za\u010daly rychle mno\u017eit, \u00fato\u010dit a likvidovat zcela specificky a naprosto p\u0159esn\u011b pouze virem infikovan\u00e9 bu\u0148ky tak, \u017ee jim \u201evst\u0159\u00edknou jed\u201c a t\u00edmto polibkem smrti je odsoud\u00ed k sebezni\u010den\u00ed.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>FIP je generalizovan\u00fd z\u00e1n\u011bt cel\u00e9ho t\u011bla \u2013 TPA tento z\u00e1n\u011bt zastavuje<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 Imunokomplexov\u00e1 patologie vyvolan\u00e1 FIP ni\u010d\u00ed c\u00e9vy, org\u00e1ny \u2013 ledviny, j\u00e1tra, srdce, nervovou soustavu. .. TPA zesiluje zv\u00fd\u0161enou disponibiln\u00ed nab\u00eddkou T lymfocyt\u016f odvozen\u00fdch z CD4+bun\u011bk a tak zprost\u0159edkovan\u011b zes\u00edlen\u00edm kontroln\u00edch mechanism\u016f blokuje pokra\u010dov\u00e1n\u00ed z\u00e1n\u011btu a stimuluje regeneraci.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>FIP je n\u00e1sledkem potla\u010den\u00ed imunitn\u00edch kontroln\u00edch mechanism\u016f \u2013 TPA ovliv\u0148uje n\u00e1vrat ke spr\u00e1vn\u00e9 regulaci.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 TPA stimuluje dozr\u00e1v\u00e1n\u00ed regula\u010dn\u00edch Treg lymfocyt\u016f, jejich\u017e \u00falohou je p\u0159ehnanou aktivitu imunitn\u00edch bun\u011bk zablokovat.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>FIP se rozvine p\u0159ednostn\u011b u imunitn\u011b oslaben\u00e9ho jedince \u2013 TPA zesiluje specifickou adaptivn\u00ed obranyschopnost.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 FIP se t\u00e9m\u011b\u0159 v\u017edy projev\u00ed u geneticky nebo jinou nemoc\u00ed imunitn\u011b oslaben\u00e9ho jedince, kter\u00fd m\u00e1 men\u0161\u00ed schopnost se br\u00e1nit. TPA (resp. Th lymfocyty) krom\u011b obecn\u00e9ho pos\u00edlen\u00ed specifick\u00fdch obrann\u00fdch mechanism\u016f efektivn\u011b pom\u00e1h\u00e1 i proti soub\u011b\u017en\u011b prob\u00edhaj\u00edc\u00edm, zejm\u00e9na virov\u00fdm infekc\u00edm (Herpes, Calicivirov\u00e1 infekce, FIV, FeLV\u2026).<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>FIP l\u00e9\u010d\u00ed antivirotika \u2013 TPA podporuje protivirovou aktivitu imunitn\u00edho syst\u00e9mu, ob\u011b terapeutick\u00e9 strategie p\u016fsob\u00ed stejn\u00fdm sm\u011brem a zesiluj\u00ed \u00fa\u010dinek l\u00e9\u010dby.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 GS-441524, Molnupiravir aj. blokuj\u00ed mno\u017een\u00ed viru, TPA zejm\u00e9na ni\u010d\u00ed infikovan\u00e9 bu\u0148ky a p\u0159isp\u00edv\u00e1 k regeneraci organismu zes\u00edlen\u00edm p\u0159irozen\u00e9 protivirov\u00e9 \u00falohy bun\u011b\u010dn\u00e9 imunity.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>Soub\u011b\u017en\u00e9 pod\u00e1v\u00e1n\u00ed nedostate\u010dn\u00e9 d\u00e1vky antivirotika a TPA sni\u017euje pravd\u011bpodobnost relapsu pro podd\u00e1vkov\u00e1n\u00ed l\u00e9\u010divem (\u0161patn\u00e1 \u0161ar\u017ee l\u00e9ku, \u0161patn\u00e1 diagnostika formy FIP, \u0161patn\u00e9 vst\u0159eb\u00e1v\u00e1n\u00ed p\u0159i l\u00e9\u010db\u011b tabletami..)<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 Antivirotika obt\u00ed\u017en\u011b pronikaj\u00ed do nervov\u00e9 soustavy, je nutn\u00e1 vysok\u00e1 d\u00e1vka. Imunitn\u00ed bu\u0148ky, kter\u00e9 specificky vyhled\u00e1vaj\u00ed naka\u017een\u00e9 makrof\u00e1gy touto bari\u00e9rou prostoupit dok\u00e1\u017e\u00ed. Pokud je l\u00e9\u010debn\u00e1 d\u00e1vka antivirotika ni\u017e\u0161\u00ed, m\u016f\u017ee se virus skr\u00fdt v mozkom\u00ed\u0161n\u00edm moku a zp\u016fsobit neurologick\u00fd relaps. Je-li za t\u011bchto okolnost\u00ed soub\u011b\u017en\u011b pod\u00e1v\u00e1n TPA, cytotoxick\u00e9 lymfocyty vyhledaj\u00ed zdroj nebezpe\u010d\u00ed i v nervov\u00e9 soustav\u011b, kam antivirotikum pronikne jen v nedostate\u010dn\u00e9m mno\u017estv\u00ed. Pod\u00e1v\u00e1n\u00ed TPA spolu s antivirotiky zvy\u0161uje jistotu uzdraven\u00ed.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>Na konci l\u00e9\u010dby b\u00fdvaj\u00ed patrn\u00e9 zn\u00e1mky imunitn\u00edho vy\u010derp\u00e1n\u00ed. TPA stimuluje obnoven\u00ed v\u0161ech imunitn\u00edch funkc\u00ed p\u0159irozen\u00fdm a tedy optim\u00e1ln\u00edm zp\u016fsobem.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 \u010cast\u00e1 je zejm\u00e9na neutropenie. Krom\u011b mo\u017en\u00e9 supresivn\u00ed role antivirotik je velmi pravd\u011bpodobn\u00e9 prost\u00e9 vy\u010derp\u00e1n\u00ed kostn\u00ed d\u0159en\u011b po ohromn\u00e9 z\u00e1t\u011b\u017ei. D\u0159e\u0148 tvo\u0159\u00ed v\u0161echny b\u00edl\u00e9 krvinky, kter\u00e9 se pod\u00edlej\u00ed na imunitn\u00edch procesech. Neutrofily (\u017eij\u00ed zhruba pouze 6 a\u017e 12 hodin a jsou jen na jedin\u00e9 pou\u017eit\u00ed, pak hynou), kter\u00e9 typicky u FIP vznikaj\u00ed a um\u00edraj\u00ed v ohromn\u00e9m mno\u017estv\u00ed mnohdy na konci l\u00e9\u010dby sch\u00e1zej\u00ed. \u010cast\u00e9 je pod\u00e1v\u00e1n\u00ed imunoglukan\u016f a jin\u00fdch podp\u016frn\u00fdch nespecifick\u00fdch imunostimulant\u016f, kter\u00e9 by m\u011bly jejich tvorbu podpo\u0159it. To se tak\u00e9 skute\u010dn\u011b d\u011bje, ale za cenu dal\u0161\u00edho vy\u010derp\u00e1v\u00e1n\u00ed kostn\u00ed d\u0159en\u011b a oddalov\u00e1n\u00ed regenerace. Nespecifick\u00e9 imunostimulanty typu imunoglukan\u016f toti\u017e t\u011blu p\u0159edkl\u00e1daj\u00ed fale\u0161n\u00fd sign\u00e1l o proniknut\u00ed patogenu, co\u017e vyvol\u00e1 nespecifickou stimulaci a zv\u00fd\u0161\u00ed n\u00e1roky na vys\u00edlenou kostn\u00ed d\u0159e\u0148, aby tvo\u0159ila dal\u0161\u00ed a dal\u0161\u00ed kr\u00e1tkov\u011bk\u00e9 bu\u0148ky, kter\u00e9 pak hynou i bez vyu\u017eit\u00ed, pouze byly kr\u00e1tk\u00fd \u010das k dispozici. TPA podporuje p\u0159irozen\u00e9 mechanismy, kter\u00e9 vys\u00edlaj\u00ed impulzy sm\u011brem k d\u0159eni pouze v p\u0159\u00edpad\u011b, \u017ee vznikne skute\u010dn\u00fd probl\u00e9m, \u017ee je nutn\u00e9 \u010delit skute\u010dn\u00e9mu nebezpe\u010d\u00ed. D\u0159e\u0148 se resetuje mo\u017en\u00e1 pomaleji, ale zdrav\u011bj\u0161\u00edm zp\u016fsobem a tak paradoxn\u011b mnohem d\u0159\u00edve a s v\u011bt\u0161\u00ed silou m\u016f\u017ee zareagovat v p\u0159\u00edpad\u011b skute\u010dn\u00e9ho nebezpe\u010d\u00ed.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>Geneticky nebo jinou nemoc\u00ed (FeLV, FIV\u2026) oslaben\u00fd jedinec, kter\u00fd ji\u017e prod\u011blal FIP je st\u00e1le v rizikov\u00e9 skupin\u011b se zv\u00fd\u0161enou pravd\u011bpodobnost\u00ed pro op\u011btovn\u00e9 propuknut\u00ed nemoci p\u0159i reinfekci.<\/strong>\u00a0<strong>TPA toto riziko sni\u017euje.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 Bylo experiment\u00e1ln\u011b i klinickou prax\u00ed uk\u00e1z\u00e1no, \u017ee stimulace adaptivn\u00ed imunity pomoc\u00ed TPA m\u00e1 potenci\u00e1l zni\u010dit st\u0159evn\u00ed infekci koronavirem a dokonce jako jedin\u00fd terapeutick\u00fd prost\u0159edek vyl\u00e9\u010dit m\u00e9n\u011b a\u017e st\u0159edn\u011b z\u00e1va\u017en\u00e9 p\u0159\u00edpady such\u00e9 formy FIP. Trval\u00e9 do\u017eivotn\u00ed posilov\u00e1n\u00ed obranyschopnosti pomoc\u00ed TPA a stimulace bun\u011b\u010dn\u00e9 imunity s jeho pomoc\u00ed m\u00e1 tedy potenci\u00e1ln\u011b ohromn\u00fd ochrann\u00fd preventivn\u00ed efekt.<\/p>\n<p class=\"lead\">\u00a0<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>TPA nem\u00e1 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">\u00a0 \u00a0 \u00a0 \u00a0Dosud bylo spot\u0159ebov\u00e1no 480 000 000 d\u00e1vek ProBoostu, zhruba 150000 d\u00e1vek LCTI a \u017e\u00e1dn\u00e9 v\u00e1\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky ani u lid\u00ed ani u zv\u00ed\u0159at nebyly pozorov\u00e1ny. Proto\u017ee je TPA p\u0159irozenou sou\u010d\u00e1st\u00ed imunitn\u00ed regulace, nen\u00ed mo\u017en\u00e9 jeho pod\u00e1v\u00e1n\u00edm na rozd\u00edl od nerozv\u00e1\u017en\u00e9 nespecifick\u00e9 imunostimulace vy\u010derpat imunitn\u00ed syst\u00e9m.<\/p>\n<ul>\n<li>\n<p class=\"lead\"><strong>Cena je velmi p\u0159\u00edzniv\u00e1.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p class=\"lead\">Je-li u\u017e\u00edv\u00e1n preventivn\u011b, sta\u010d\u00ed pro jednu ko\u010di\u010dku pouh\u00e1 jedna a\u017e dv\u011b krabi\u010dky na rok, \u00fatulk\u016fm, z\u00e1chran\u00e1\u0159\u016fm, majitel\u016fm chronick\u00fdch pacient\u016f a ko\u010dek l\u00e9\u010den\u00fdm na FIP nav\u00edc poskytujeme 5 a\u017e 10% slevy. Ve srovn\u00e1n\u00ed s cenou l\u00e9\u010dby relapsu nebo veterin\u00e1rn\u00edmi n\u00e1klady na l\u00e9\u010dbu nevratn\u00fdch n\u00e1sledk\u016f FIP je soub\u011b\u017en\u00e9 pod\u00e1v\u00e1n\u00ed ProBoostu b\u011bhem l\u00e9\u010dby zcela zanedbateln\u00e9.<\/p>\n\t\t\n<style>\n#text-2184785370 {\n  font-size: 0.75rem;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"row\"  id=\"row-894682706\">\n\n\n\t<div id=\"col-1776694964\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<h4 class=\"x1e56ztr\" style=\"text-align: center;\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">Jak tedy zjednodu\u0161en\u011b Thymov\u00fd protein A (LCTI \u2013 Lymphocyte T-Cell Immunomodulator ) p\u016fsob\u00ed.<\/span><\/h4>\n<div class=\"x1e56ztr\" style=\"text-align: center;\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\"><b>TEORIE&nbsp;<\/b><\/span><\/div>\n<div>&nbsp;<\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">&nbsp; &nbsp; &nbsp; Je zn\u00e1ma jeho <b>p\u0159esn\u00e1 molekul\u00e1rn\u00ed struktura<\/b>&nbsp;<b>i<\/b>&nbsp;<b>mechanismus p\u016fsoben<\/b>\u00ed (<a class=\"x1i10hfl xjbqb8w x6umtig x1b1mbwd xaqea5y xav7gou x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 x1hl2dhg xggy1nq x1a2a7pz xt0b8zv x1fey0fg\" tabindex=\"0\" role=\"link\" href=\"https:\/\/proboostnow.eu\/en_us\/co-je-thymic-protein-a\/?fbclid=IwAR1cf_1338YEskqplk1ba1SMpx5ZPlncyZuXB-dbeokB_SUYmdm4GV9G1zM\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">https:\/\/proboostnow.eu\/co-je-thymic-protein-a\/<\/a>)&nbsp;<b>m\u00edsto synt\u00e9zy<\/b>&nbsp;(<i>epiteli\u00e1ln\u00ed bu\u0148ky brzl\u00edkov\u00e9ho kortexu<\/i>) i&nbsp;<b>biologick\u00fd \u00fa\u010dinek TPA&nbsp;<\/b>&nbsp;Lze ho popsat jako&nbsp;<b>p\u0159\u00edkaz&nbsp;<\/b>(<i>diferencia\u010dn\u00ed sign\u00e1l prost\u0159ednictv\u00edm transkrip\u010dn\u00edho faktoru NF-Kb<\/i>)&nbsp;<b>nezral\u00fdm b\u00edl\u00fdm krvink\u00e1m \u2013 T lymfocyt\u016fm<\/b>, kter\u00e9 vzniknou v kostn\u00ed d\u0159eni,&nbsp;<b>aby dosp\u011bly&nbsp;<\/b>v pln\u011b funk\u010dn\u00ed CD 4+ lymfocyty a d\u00e1le ovliv\u0148uje jejich aktiva\u010dn\u00ed proces, kter\u00fd nastane ji\u017e p\u0159\u00edmo jako reakce na konkr\u00e9tn\u00ed virovou infekci a to takov\u00fdm zp\u016fsobem, \u017ee stimuluje lymfocyty ve f\u00e1zi, kdy se rozhoduje o tom, jak\u00fdm sm\u011brem se bude obrana rozv\u00edjet,&nbsp;<b>aby zah\u00e1jily p\u0159ednostn\u011b protivirov\u00fd typ imunitn\u00ed odpov\u011bdi<\/b>&nbsp;<b>(Th1).<\/b>&nbsp;T lymfocyty jsou \u0159\u00edd\u00edc\u00ed jednotkou nej\u00fa\u010dinn\u011bj\u0161\u00edho obrann\u00e9ho mechanismu, kter\u00fdm t\u011blo disponuje. Na nich z\u00e1vis\u00ed odstartov\u00e1n\u00ed spr\u00e1vn\u00e9, p\u0159im\u011b\u0159en\u00e9 a p\u0159esn\u00e9 reakce na infekci, \u0159\u00edzen\u00ed jej\u00edho pr\u016fb\u011bhu a ukon\u010den\u00ed ve chv\u00edli, kdy je virus zni\u010den. Z\u00e1rove\u0148 je v nich uchov\u00e1na pam\u011b\u0165 na virus a jsou nositeli \u201eimunizace\u201c proti dal\u0161\u00ed infekci stejn\u00fdm virem (princip o\u010dkov\u00e1n\u00ed).<\/span><\/div>\n<div>&nbsp;<\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">&nbsp; &nbsp; &nbsp; &nbsp;To, co se d\u011bje v organismu ko\u010dky b\u011bhem nemoci je projevem \u0161patn\u00e9 a p\u0159ehnan\u00e9 imunitn\u00ed reakce (<i>Th2- protil\u00e1tkov\u00e1 reakce \u2013 FIP je imunokomplexov\u00e1 nemoc<\/i>), kterou vyvol\u00e1 p\u0159\u00edtomnost viru v imunitn\u00edch bu\u0148k\u00e1ch (<i>makrof\u00e1z\u00edch<\/i>). Zjednodu\u0161en\u011b \u0159e\u010deno,&nbsp;<b>virus imunitu zmate a ta zareaguje \u0161patn\u011b, co\u017e m\u00e1 za n\u00e1sledek, \u017ee za\u010dne ni\u010dit vlastn\u00ed c\u00e9vy a org\u00e1ny.<\/b>&nbsp;<b>Pod\u00e1v\u00e1n\u00ed b\u011b\u017en\u00fdch nespecifick\u00fdch imunostimulant\u016f (imunoglukany, zylexis, fosprenil\u2026) tento \u0161patn\u00fd proces je\u0161t\u011b zesiluje a nemoc je\u0161t\u011b v\u00edce zhor\u0161uje.&nbsp;<\/b>Pod\u00e1n\u00ed&nbsp;<b>TPA&nbsp;<\/b>p\u016fsob\u00ed proti n\u011bmu<b>&nbsp;\u2013 zablokuje \u0161patnou Th2<\/b>&nbsp;(<i>pomoc\u00ed chemick\u00fdch sign\u00e1l\u016f p\u0159i diferenciaci<\/i>) a naopak&nbsp;<b>stimuluje protivirovou Th1<\/b>&nbsp;(<i>prok\u00e1z\u00e1no jak p\u0159\u00edmo na thymocytech in vitro v laborato\u0159i, tak m\u011b\u0159en\u00edm u \u017eiv\u00fdch organism\u016f in vivo<\/i>\u2026..)<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">.<\/span><\/div>\n<div class=\"row\"  id=\"row-669390626\">\n\n\n\t<div id=\"col-756438174\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">.<\/span><\/div>\n<div class=\"x1e56ztr\" style=\"text-align: center;\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\"><b>PRAXE<\/b><\/span><\/div>\n<div>\u00a0<\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">\u00a0 \u00a0 \u00a0 V roce 2009, tedy v dob\u011b, kdy je\u0161t\u011b nebyla mo\u017enost l\u00e9\u010dby modern\u00edmi antivirotiky byl pou\u017eit LTCI (injek\u010dn\u00ed forma s obsahem TPA) v z\u00e1chrann\u00e9 organizaci Healing Hearts Animal Rescue v Nashvillu a bylo zdokumentov\u00e1no kompletn\u00ed uzdraven\u00ed v\u0161ech 15 ko\u010dek se suchou formou FIP, kter\u00fdm byl LCTI pod\u00e1v\u00e1n (m\u00edrn\u00e9 a\u017e st\u0159edn\u00ed projevy nemoci).<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\"><b>U v\u0161ech 15 ko\u010dek se suchou FIP l\u00e9\u010denou LTCI(=TPA) do\u0161lo k \u00fapln\u00e9mu vymizen\u00ed koronaviru z t\u011bla v obou jeho form\u00e1ch\u00a0<i>(FeCoV, FIPV)<\/i>.<\/b><\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\"><a class=\"x1i10hfl xjbqb8w x6umtig x1b1mbwd xaqea5y xav7gou x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 x1hl2dhg xggy1nq x1a2a7pz xt0b8zv x1fey0fg\" tabindex=\"0\" role=\"link\" href=\"https:\/\/proboostnow.eu\/en_us\/healing-hearts-animal-rescue-v-nashvillu-lecba-suche-fip-pomoci-lcti\/?fbclid=IwAR2F1EwCVqbWJQzeDnDHIqPESxsTNrZGZEebpbP81R3UNvBjqRWwJv-e54o\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">https:\/\/proboostnow.eu\/healing-hearts-animal-rescue-v\u2026\/<\/a><\/span><\/div>\n<div>\u00a0<\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">V \u017e\u00e1dn\u00e9m p\u0159\u00edpad\u011b netvrd\u00edme, \u017ee ProBoost je vhodn\u00fd jako jedin\u00fd l\u00e9k na FIP. To by bylo nezodpov\u011bdn\u00e9 a zejm\u00e9na u t\u011b\u017e\u0161\u00edch p\u0159\u00edpad\u016f a hlavn\u011b u akutn\u00ed mokr\u00e9 FIP i \u017eivot ohro\u017euj\u00edc\u00ed. Co je v\u0161ak ji\u017e na tis\u00edc\u00edch p\u0159\u00edpad\u016f v zahrani\u010d\u00ed prok\u00e1z\u00e1no je to, \u017ee Thymov\u00fd Protein A je nesm\u00edrn\u011b\u00a0<b>\u00fa\u010dinn\u00fd prost\u0159edek pozitivn\u011b ovliv\u0148uj\u00edc\u00ed imunitu p\u0159i l\u00e9\u010db\u011b antivirotiky<\/b>. Vyl\u00e9\u010den\u00ed z FIP je vlastn\u011b vyl\u00e9\u010den\u00ed imunitn\u00edho syst\u00e9mu, kter\u00fd je b\u011bhem nemoci v rozvratu. To, co sledujeme jako laboratorn\u00ed markery pro ukon\u010den\u00ed l\u00e9\u010dby antivirotiky je v podstat\u011b to, zda imunitn\u00ed syst\u00e9m zase funguje tak jak m\u00e1.<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">Proto je d\u016fle\u017eit\u00fd vy\u0161\u0161\u00ed po\u010det lymfocyt\u016f na konci l\u00e9\u010dby a zv\u00fd\u0161en\u00ed pom\u011bru A\/G \u2013 tedy poklesu mno\u017estv\u00ed protil\u00e1tek.\u00a0<b>Dokud k tomuto resetu nedojde, prob\u00edh\u00e1 neust\u00e1le po\u0161kozov\u00e1n\u00ed v\u0161ech org\u00e1n\u016f v t\u011ble<\/b>. Je tedy logick\u00e9, \u017ee\u00a0<b>\u010d\u00edm d\u0159\u00edve je zastavena destrukce<\/b>\u00a0(Th2) a p\u0159evezme ot\u011b\u017ee kompetitivn\u00ed Th1,\u00a0<b>t\u00edm men\u0161\u00ed je celkov\u00e9 po\u0161kozen\u00ed, kter\u00e9 je nutn\u00e9 opravit, pokud to je\u0161t\u011b lze<\/b>. FIP m\u016f\u017ee zni\u010dit nevratn\u011b funk\u010dnost n\u011bkter\u00fdch org\u00e1n\u016f, krom\u011b nejposti\u017een\u011bj\u0161\u00edch ledvin a obecn\u011b c\u00e9vn\u00edho syst\u00e9mu, je to i srdce nebo CNS. Proto je velice u\u017eite\u010dn\u00e9 zkr\u00e1tit dobu pot\u0159ebnou k uzdraven\u00ed v\u0161emi vhodn\u00fdmi prost\u0159edky. Pokud je b\u011bhem terapie pod\u00e1v\u00e1n TPA, m\u016f\u017ee nap\u0159\u00edklad p\u0159edej\u00edt po\u0161kozen\u00ed srdce virovou infekc\u00ed a pokud k n\u00ed dojde, je prosp\u011b\u0161n\u00fdm terapeutick\u00fdm dopl\u0148kem pro podporu farmakologick\u00e9 l\u00e9\u010dby kardiaka.<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">O TPA v souvislosti s FIP, nemus\u00edme ji\u017e na\u0161t\u011bst\u00ed \u010derpat zku\u0161enosti jen ze zahrani\u010d\u00ed, kde je ProBoost standardn\u011b pou\u017e\u00edv\u00e1n, ale m\u00e1me mnoho \u00fasp\u011bch\u016f i u n\u00e1s. Majitel\u00e9 ko\u010di\u010d\u00edch pacient\u016f n\u00e1m hl\u00e1s\u00ed a\u017e p\u0159ekvapiv\u011b pozitivn\u00ed efekt pod\u00e1v\u00e1n\u00ed ProBoostu a to nejen na pr\u016fb\u011bh samotn\u00e9 l\u00e9\u010dby.<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">Zaznamenali jsme \u010detn\u00e9 p\u0159\u00edpady vyl\u00e9\u010den\u00ed ko\u010dek p\u0159i pou\u017eit\u00ed n\u00edzk\u00e9ho po\u010dtu d\u00e1vek antivirotik . U neurologick\u00e9 FIP sta\u010dilo k uzdraven\u00ed v jednom konkr\u00e9tn\u00edm p\u0159\u00edpad\u011b pouh\u00fdch 25 d\u00e1vek, u t\u011b\u017ek\u00e9 efuzn\u00ed formy 10,\u00a0 extr\u00e9mn\u00ed p\u0159\u00edpad je u kocoura s neurologickou formou FIP vyl\u00e9\u010den\u00e9ho na 7 d\u00e1vk\u00e1ch 8 mg\/kg, i u n\u00e1s jsme ji\u017e zaznamenali dva p\u0159\u00edpady such\u00e9 FIP, kter\u00e1 byla zcela terapeuticky zvl\u00e1dnuta pouze stimulac\u00ed imunity pod\u00e1v\u00e1n\u00edm TPA.\u2026. (<a class=\"x1i10hfl xjbqb8w x6umtig x1b1mbwd xaqea5y xav7gou x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 x1hl2dhg xggy1nq x1a2a7pz xt0b8zv x1fey0fg\" tabindex=\"0\" role=\"link\" href=\"https:\/\/l.facebook.com\/l.php?u=https%3A%2F%2Fproboostnow.eu%2Ffip-infekcni-peritonitida-kocek%2F%3Ffbclid%3DIwAR3iR1b3A9wLvFK9xsVUoWE7yHGyf_hnLiWI3N1yK7sKojpoMJJS-HfS49E&amp;h=AT1uc7_4lERmMdZr1l8xIv4t5u1eoA--yMPaOxl0btR6lp6EoZHu1c-njwtxtiwxpGy48Y2UbxRzTu4krSgIRMo8h6kenQcnau6p5BRvzoDMsa1EUIXOiN7p2497NvjCcA8v&amp;__tn__=-UK-R&amp;c&#091;0&#093;=AT35Q1lrRtTkLjx2ywpvW8xoHIc4-8g9zcGEGvAbO-skhPsCGxwPg8ai5BjchvCmLmdNR7ONV59DihrtTopxB8gTKgWHC7DgH8enfy41e8bELkV7Df0j_40sXoN8z5sORTXVS5vsuBuhV4MW6U8ykz6UXzmp4HRYLmI4YXJfICNwpiLeXd6_GusLUB5kZPQLxgo4jKZz9Zn6VAHwldTCdMo\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">https:\/\/proboostnow.eu\/fip-infekcni-peritonitida-kocek\/<\/a>).<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">Obecn\u011b je pozorov\u00e1no v\u00fdznamn\u011b rychlej\u0161\u00ed zv\u00fd\u0161en\u00ed hladiny lymfocyt\u016f a rychlej\u0161\u00ed pokles globulinov\u00e9 frakce.<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">Vzhledem k mechanismu \u00fa\u010dinku a potenci\u00e1lu zbavit organismus koronaviru je vhodn\u00e9 preventivn\u00ed pod\u00e1v\u00e1n\u00ed ProBoostu jak u vyl\u00e9\u010den\u00fdch zv\u00ed\u0159at, tak u jejich p\u0159\u00edbuzn\u00fdch, ohro\u017een\u00fdch genetickou predispozic\u00ed.<\/span><\/div>\n<div class=\"x1e56ztr\"><span class=\"x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x6prxxf xvq8zen xo1l8bm xzsf02u\">Odpov\u011bdnost za propuknut\u00ed FIP maj\u00ed i environment\u00e1ln\u00ed podm\u00ednky, jin\u00e1 onemocn\u011bn\u00ed, stres\u2026 v\u0161echny tyto aspekty p\u016fsob\u00ed na sn\u00ed\u017een\u00ed obranyschopnosti. Je tedy na m\u00edst\u011b zejm\u00e9na v prost\u0159ed\u00ed s p\u0159edchoz\u00edm v\u00fdskytem FIP (mo\u017en\u00fd v\u00edce patogenn\u00ed kmen viru) podporovat imunitu t\u00edmto zp\u016fsobem a ji\u017e v po\u010d\u00e1tku chybnou destruktivn\u00ed odpov\u011b\u010f na infekci makrof\u00e1g\u016f zastavit pod\u00e1v\u00e1n\u00edm TPA a tak zablokovat rozvoj nemoci.<\/span><\/div>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":2684,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"jetpack_featured_media_url":"https:\/\/proboostnow.eu\/wp-content\/uploads\/2023\/06\/Screenshot-2023-06-04-155109.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/posts\/2822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/comments?post=2822"}],"version-history":[{"count":0,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/posts\/2822\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/media\/2684"}],"wp:attachment":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/media?parent=2822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/categories?post=2822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/tags?post=2822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}